ラミプリルと糖尿病の発症
S Yusuf1, H Gerstein, B Hoogwerf
1Canadian Cardiovascular Collaboration Project Office, Hamilton General Hospital, 237 Barton St East, Hamilton, Ontario, Canada L8L 2X2. yusufs@mcmaster.ca
JAMA
|October 26, 2001
まとめ
アンジオテンシン変換酵素阻害剤であるラミプリルは,リスクの高い個体において,糖尿病の新規診断を大幅に減少させた. この発見は,ラミプリルが2型糖尿病の潜在的な予防戦略であることを示唆しています.
科学分野:
- 心臓病学 心臓病学
- エンドクリノロジー エンドクリノロジー
- 薬理学 薬理学とは
背景:
- 2型糖尿病は,世界的な健康上の大きな課題となっています.
- 糖尿病予防のための従来のライフスタイル変更戦略には限界があります.
- 代替的な予防方法を探求することは極めて重要です.
研究 の 目的:
- 糖尿病の発症を予防するアンジオテンシン変換酵素阻害剤であるラミプリルの有効性を評価する.
- 糖尿病予防のための高リスク集団におけるラミプリルの役割を評価する.
主な方法:
- ハートアウトカムズ予防評価 (HOPE) 試験は,ランダム化され,コントロールされた試験でした.
- 55歳以上で血管疾患を患っている5720人の患者を対象にしたが,糖尿病は認められなかった.
- 参加者はラミプリル (最大10mg/日) またはプラセボを投与された.
主要な成果:
- ラミプリルグループでは,プラセボと比較して糖尿病の新規診断が34%減少した (3.6%対5.4%).
- 新しい糖尿病診断の相対リスクは0.66 (95%CI,0.51-0.85;P<.001) でした.
- 様々な診断基準とサブグループで一貫した利点が観察されました.
結論:
- ラミプリルは,リスクの高い個体における新規発症糖尿病の減少と有意な関連性を示した.
- これらの発見は,糖尿病の予防に臨床および公衆衛生上の潜在的な影響を及ぼします.
- これらの結果を確認するために,さらなる見通し研究が必要である.
さらに関連する動画
関連する概念動画
01:25Antihypertensive Drugs: Direct Renin Inhibitors
1.2K
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
1.2K
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
823
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
823
01:30Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
2.2K
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
2.2K
01:30Antihypertensive Drugs: Angiotensin II Receptor Blockers
2.2K
In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
2.2K
01:23Dipeptidyl Peptidase 4 Inhibitors
489
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
489
01:28Antihypertensive Drugs: Potassium-Sparing Diuretics
2.1K
Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
2.1K